Background：The product of this gene belongs to the family of highly homologous synovial sarcoma X （SSX） breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. This gene, and also the SSX1 and SSX4 family members, have been involved in t（X;18）（p11.2;q11.2） translocations that are characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are likely responsible for transforming activity. Alternative splicing of this gene results in multiple transcript variants. This gene also has an identical duplicate, GeneID： 727837, located about 45 kb downstream in the opposite orientation on chromosome X.
仕様
Synonyms：Cancer/testis antigen 5.2,Cancer/testis antigen family 5,member 2a,Cancer/testis antigen family 5,member 2b,CT5.2,CT5.2A,CT5.2b,HD21,hom mel 40,HOM-MEL-40,MGC119055,MGC15364,MGC3884,Protein SSX2,RP11-552J9.2,sarcoma,synovial,X-chromosome related 2,SSx,SSX2,SSX2-SYT fusion gene,included,SSX2,SSX2B,Synovial sarcoma,synovial sarcoma X breakpoint 2,Synovial sarcoma,X breakpoint 2B,Tumor antigen HOM-MEL-40,X breakpoint 2
Host：Rabbit
Reactivity：Human,Mouse,Rat
Applications：IF
Concentration：1mg/ml
Immunogen：Recombinant protein of human SSX2
Purification Method：Affinity purification
Clonality：Polyclonal
Conjugation：Unconjugated
Buffer：Buffer： PBS with 0.02％ sodium azide, 50％ glycerol, pH7.3.
